Johnson & Johnson of New Brunswick, NJ, said it has completed its acquisition of vascular device developer Conor Medsystems.
The Menlo Park, CA-based Conor manufactures a drug-eluting cobalt chromium stent. J&J said that it will be exploring the potential for the technology in combination with other pharmaceutical agents and delivery systems.
By AuntMinnie.com staff writers
February 2, 2007
Related Reading
Conor shareholders OK J&J acquisition, February 1, 2007
Conor wins British patent victory, January 16, 2007
J&J's Conor acquisition gets FTC OK, January 9, 2007
Conor licenses Novartis technology, March 16, 2006
Conor Medsystems initiates CoStar II trial, May 24, 2005
Copyright © 2007 AuntMinnie.com